Peptide-Based Therapies Show Promise in Wound Care Pipeline
Several peptide-loaded hydrogels are already in Phase 3 clinical trials for chronic and acute wound care, signaling an accelerating transition from bench to pharmacy shelf.
#drug delivery
2 stories
iRGD-PLGA Nanocomplex Targets Chemoresistant Colon Cancer
Researchers engineered PLGA nanocomplexes functionalized with iRGD tumor-penetrating peptides to deliver paclitaxel combined with medicinal fungus extract, targeting the PDCD4 gene to overcome drug resistance.